SCHEMBL21297764

SCHEMBL21297764

N#Cc1c(C#N)c(C#N)c2cc3c(cc2c1C#N)c1nccnc1c1ccc2ccccc2c31

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
HPGD P15428 2/20 0.37
CYP1A2 P05177 1/20 0.37
GAA P10253 1/20 0.37
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ANPEP P15144 1/20 0.34
PIM1 P11309 1/20 0.34
L3MBTL1 Q9Y468 4/20 0.33
CCR1 P32246 3/20 0.33
CCR8 P51685 3/20 0.33
MAPK1 P28482 3/20 0.33
LMNA P02545 2/20 0.33
APEX1 P27695 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21298452 0.90 ALDH1A1 (0.36) CYP3A4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21298443 0.89 ALDH1A1 (0.39) CYP3A4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21297904 0.86 KDM4E (0.37) CYP3A4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21297876 0.86 KDM4E (0.40) CYP3A4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21297762 0.83 KDM4E (0.39) CYP3A4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21298246 0.82 ALDH1A1 (0.40) CYP3A4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21297826 0.82 ALDH1A1 (0.38) CYP3A4ALDH1A1KDM4EMAPTKMT2A
SCHEMBL21298199 0.82 ALDH1A1 (0.42) CYP3A4ALDH1A1KDM4EMAPTHPGD
SCHEMBL21298477 0.81 KDM4E (0.35) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL21297766 0.77 HPRT1 (0.48) CYP3A4ALDH1A1KDM4EMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNIV ARIZONA STATE (US) 2023-06-22 US disclosed
US-20210024526-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNITED STATES DEPARTMENT OF ENERGY 2021-01-28 US disclosed
US-10851106-B2 Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-12-01 US disclosed
US-20200071330-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS UNITED STATES DEPARTMENT OF ENERGY 2020-03-05 US disclosed
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2019-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024526-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS CYP3A4 2938/4885ALDH1A1 2839/4885KDM4E 3740/4885
US-20200071330-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS CYP3A4 2938/4885ALDH1A1 2839/4885KDM4E 3740/4885
US-20230192695-A1 THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS TTPA, TTC14, AAAS CYP3A4 2938/4885ALDH1A1 2839/4885KDM4E 3740/4885
US-10851106-B2 Substituted benzo[4,5]imidazo[1,2-F]phenanthridines, dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzofurophenanthridines and dibenzo[I.K]benzo[4,5]imidazo[1,2-F]benzo[4,5]thienophenanthridines as thermally assisted delayed fluorescent materials KCNK4, TRPC4, TBRG4 CYP3A4 34/4885ALDH1A1 566/4885KDM4E 731/4885
US-10392387-B2 Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials NT5C, HTR3D, IK CYP3A4 320/4885ALDH1A1 326/4885KDM4E 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.